期刊文献+

鲍曼不动杆菌OXA-23型碳青霉烯酶基因的研究 被引量:14

OXA-23 carbapenemase-encoding gene of Acinetobacter baumannii
在线阅读 下载PDF
导出
摘要 目的分析鲍曼不动杆菌的耐药性及其产OXA-23型碳青霉烯酶基因的核苷酸序列。方法用自动微生物分析仪测定常用抗菌药的M IC50;对OXA-23型碳青霉烯酶基因进行PCR扩增,产物纯化测序。结果15株产ESBL s鲍曼不动杆菌中有12株携带OXA-23型碳青霉烯酶;PCR产物纯化后测序表明与鲍曼不动杆菌(AY 795964.1)blaOXA-23基因序列100%同源。结论携带OXA-23型碳青霉烯酶基因的鲍曼不动杆菌对临床常用抗菌药的耐药率高,其编码基因为blaOXA-23。 emase-encoding ge Objective To analyze drug resistance of Acineiobacter baumannii and it's OXA-23 carbapenne. Methods PCR amplification was performed of OXA-23 carbapenemase-encoding gene plasmid by PCR, PCR products purifing and nucleotide sequencing. Results There were 12 OXA-23 carbapenemase-producing strains in 15 isolates of ESBLs (+) A. baumannii. Sequencing analysis of this product revealed 100% identity with blaoxA.23 which was originally detected in another strain of A. baumannii (AY795964. 1). Conclusion An isolate of Acinetobacter baumannli producing OXA-23 carbarpenase was highly resistant to commonly use antibiotics and it's encoding gene is blaoxA-23.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2007年第2期123-124,127,共3页 Chinese Journal of Antibiotics
基金 江西省卫生厅课题(20043143)
关键词 鲍曼不动杆菌 碳青霉烯酶 基因 Acinetobacter baumannii Carbapenemase Gene
作者简介 李蓉,女,生于1973年.博士,副教授。研究方向;细菌耐药机制。 通讯作者:E—mail:liwenlin999@sina.com
  • 相关文献

参考文献9

  • 1Dalla-Costa L M, Coelho J M, Souza H A P H M, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazll [J]. J Clin Microbiol, 2003,41 (7):3403
  • 2Simhon A, Rahav G, Shazberg G, et al. Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem [J]. J Clin Microbiol, 2001.39 (1):389
  • 3Corbella X, Montero A, Pujol M, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii [J]. J Clin Microbiol, 2000,38(11 ) ; 4086
  • 4蒋晓飞,乐军,洪秀华,朱月秋,王洪海,倪语星.一株同时产OXA-23型碳青霉烯水解酶和PER-1型超广谱β-内酰胺酶的鲍曼不动杆菌[J].上海医学检验杂志,2002,17(5):263-267. 被引量:29
  • 5Yu Y S, Yang.Q, Xu X W, et al. Typing and characterization of carbapenem-resistant Zcinetobacter calcoaceticusbaumannii complex in a Chinese hospital [J]. J Med Microbiol, 2004,53 (7) : 653
  • 6Silva G J D, Leitao R, Peixe L. Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannil clinical isolates [J]. J Clin Microbiol,1999,37(6):2109
  • 7Lopez-Otsoa F, Gallego L, Towner K J, et al. Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain [J]. J Clin Microbiol, 2002.40(12) :4741
  • 8杨青,徐小微,俞云松,孔海深,徐根云,钟步云.碳青霉烯类耐药鲍曼不动杆菌流行病学及碳青霉烯酶类型的研究[J].中华检验医学杂志,2003,26(6):342-345. 被引量:111
  • 9张永,唐英春,陆坚,张扣兴.鲍曼不动杆菌对亚胺培南耐药分子机制的研究[J].中国抗生素杂志,2005,30(4):217-221. 被引量:71

二级参考文献25

  • 1Forster DH, Daschner FD. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis, 1998,17:73-77.
  • 2Afzal-Shah M, Livermore DM. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother, 1998,41:576-577.
  • 3Seifert H, Gerner-Smidt P. Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates. J Clin Microbiol, 1995,33 : 1402-1407.
  • 4Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis:criteria for bacterial strain typing. J Clin Microbiol,1995,33:2233-2239.
  • 5Afzal-Shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother, 2001,45 :583-588.
  • 6Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents, 2003,21:58-62.
  • 7Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect, 2002,8:321-331.
  • 8Donald HM, Scaife W, Amyes SG. et al. Sequence analysis of ARI-1, a novel OXA beta -lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother,2000,44:196-199.
  • 9Jain R, Danziger L H. Multidrug-resistant acinetobacter infections: an emerging challenge to clinicians [J]. Ann Pharmacother, 2004,38(9): 1449.
  • 10Brown S, Bantar C, Young H K, et al. Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2[J]. Lancet, 1998,351 (9097): 186.

共引文献189

同被引文献128

引证文献14

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部